Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. QIAGEN N.V.
  6. News
  7. Summary
    QGEN   NL0012169213

QIAGEN N.V.

(QGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

QIAGEN N.V. : Notification and public disclosure of transactions by persons

04/16/2021 | 04:08pm EDT


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

16.04.2021 / 22:07
The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title:
First name: Roland
Last name(s): Sackers

2. Reason for the notification

a) Position / status
Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
QIAGEN N.V.

b) LEI
54930036WK3GMCN17Z57 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
Description: Transaction completed as part of a longterm 10b5-1 trading plan to sell shares of QIAGEN N.V. (ISIN: NL0012169213) at a predetermined price.

b) Nature of the transaction
Disposal

c) Price(s) and volume(s)
Price(s) Volume(s)
52.00 USD 1560000.00 USD

d) Aggregated information
Price Aggregated volume
52.00 USD 1560000.00 USD

e) Date of the transaction
2021-04-13; UTC+2

f) Place of the transaction
Name: New York Stock Exchange
MIC: XNYS



16.04.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: QIAGEN N.V.
Hulsterweg 82
5912 PL Venlo
Netherlands
Internet: www.qiagen.com

 
End of News DGAP News Service

65398  16.04.2021 


ę EQS 2021
All news about QIAGEN N.V.
04:41aQIAGEN Ná : Coronavirus Antibody Test Gets FDA Nod for Emergency Use
MT
05/12QIAGEN Ná : 2020 Annual Financial Report
PU
05/12QIAGEN Ná : Receives U.S. FDA Emergency Use Authorization for Fast and Easy-to-U..
BU
05/07DGAP-PVRá : QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG ..
DJ
05/06QIAGEN Ná : Clinical Laboratory Tests Market To Demonstrate Massive Growth By 20..
AQ
05/06QIAGEN NVá : Buy rating from Deutsche Bank
MD
05/05QIAGEN NVá : Receives a Buy rating from Kepler Cheuvreux
MD
05/05QIAGEN Ná : And subsidiaries u.s. gaap quarterly report for the period ended mar..
PU
05/05QIAGEN Ná : Chief Financial Officer
PU
05/05QIAGEN N.V. : Release according to Article 50 of the WpHG [the German Securities..
EQ
More news
Financials (USD)
Sales 2021 2 267 M - -
Net income 2021 482 M - -
Net Debt 2021 882 M - -
P/E ratio 2021 22,0x
Yield 2021 -
Capitalization 10 571 M 10 571 M -
EV / Sales 2021 5,05x
EV / Sales 2022 5,00x
Nbr of Employees 5 750
Free-Float 98,1%
Chart QIAGEN N.V.
Duration : Period :
QIAGEN N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QIAGEN N.V.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 58,33 $
Last Close Price 46,28 $
Spread / Highest target 55,6%
Spread / Average Target 26,0%
Spread / Lowest Target -11,4%
EPS Revisions
Managers and Directors
NameTitle
Thierry Bernard Chief Executive Officer & Managing Director
Roland Sackers Chief Financial Officer & Managing Director
Lawrence A. Rosen Chairman-Supervisory Board
Barthold Piening Senior Vice President & Head-Global Operations
Metin Colpan Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
QIAGEN N.V.-12.43%10 571
MODERNA, INC.46.15%61 305
LONZA GROUP AG-1.83%45 649
IQVIA HOLDINGS INC.27.25%43 699
CELLTRION, INC.-26.88%31 675
SEAGEN INC.-17.34%26 272